Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Chisholm

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 19, 1995
General practice's last standJ W Chisholm
BMJ (Clinical Research Ed.)|March 31, 1990
The 1990 contract: its history and its contentJ W Chisholm
Biochimica Et Biophysica Acta|February 23, 1972
Uncoiling of bacteriophage PM2 DNA by binding of steroidal diaminesM J Waring, J W Chisholm
Journal of Lipid Research|May 1, 1996
Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasisJ W Chisholm, P J Dolphin
Journal of Lipid Research|August 3, 1999
Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferaseJ W Chisholm, A K Gebre, J S Parks
Biochimica Et Biophysica Acta|October 6, 2000
Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCATJ W Chisholm, J R Paterniti, P J Dolphin
The American Journal of Physiology|May 18, 1999
High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesisJ W Chisholm, P Nation, P J Dolphin, et al.
Diabetes, Obesity & Metabolism|May 23, 2008
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic ratsA K Dhalla, M Santikul, J W Chisholm, et al.
Atherosclerosis|September 16, 1999
Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144E M Teh, J W Chisholm, P J Dolphin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 19, 1995
General practice's last standJ W Chisholm
BMJ (Clinical Research Ed.)|March 31, 1990
The 1990 contract: its history and its contentJ W Chisholm
Biochimica Et Biophysica Acta|February 23, 1972
Uncoiling of bacteriophage PM2 DNA by binding of steroidal diaminesM J Waring, J W Chisholm
Journal of Lipid Research|May 1, 1996
Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasisJ W Chisholm, P J Dolphin
Journal of Lipid Research|August 3, 1999
Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferaseJ W Chisholm, A K Gebre, J S Parks
Biochimica Et Biophysica Acta|October 6, 2000
Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCATJ W Chisholm, J R Paterniti, P J Dolphin
The American Journal of Physiology|May 18, 1999
High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesisJ W Chisholm, P Nation, P J Dolphin, et al.
Diabetes, Obesity & Metabolism|May 23, 2008
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic ratsA K Dhalla, M Santikul, J W Chisholm, et al.
Atherosclerosis|September 16, 1999
Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144E M Teh, J W Chisholm, P J Dolphin, et al.
Pageof 1